CAS: 7280-37-7; [(8R,9S,13S,14S)-13-Methyl-17-Oxo-7,8,9,11,12,14,15,16-Octahydro-6H-Cyclopenta[a]Phenanthren-3-Yl] Hydrogen Sulfate,Piperazine

该化合物是一种合成雌激素,特别是雌激素的衍生物,主要用于激素替代疗法和更年期症状的治疗;Ogen具有与雌激素受体结合的能力,从而模仿体内自然雌激素的影响;该化合物通常以口服形式施用,并因其在缓解与更年期有关的热闪光和阴道干燥等症状方面的作用而闻名;此外,在某些情况下,它可能被用来防止绝经后妇女骨质疏松症;与其他雌激素一样,Ogen可以产生副作用,包括血栓事件的风险增加,对乳房组织的潜在影响;其致癌主要涉及肝脏的代谢,而且对于用户来说重要的是,保健专业人员必须进行监测,以管理与其使用有关的任何风险.

结构式图片

欧盟法规

ECHA物质ECHA物质C&L通报REACH预注册

上下游产品

piperazine estrone sulfate

合成工艺路线路线简述

    哌嗪,普力马林 以 二氯甲烷 作为反应溶剂,以83.2%的收率获得产物雌酮硫酸酯哌嗪
    参考文献:雌酚酮硫酸酯哌嗪的制备方法
    标题:雌酚酮硫酸酯哌嗪的制备方法
    摘要:本文发明涉及一种高纯度雌‑1,3,5(10)‑三烯‑17‑酮‑3‑硫酸酯哌嗪(1:1)(即雌酚酮硫酸酯哌嗪)的制备方法.该方法反应条件温和,后处理操作简单,杂质容易控制,从而使制备的雌酚酮硫酸酯哌嗪质量可控,稳定性高.主要的步骤是:1)将雌酚酮溶解在有机溶剂中与磺化试剂反应得到雌‑1,3,5(10)‑三烯‑17‑酮‑3‑硫酸酯;2)将哌嗪溶解在有机溶剂中,然后加入到雌‑1,3,5(10)‑三烯‑17‑酮‑3‑硫酸酯的有机溶液中,析出固体,过滤,洗涤,干燥得到高纯度的雌酚酮硫酸酯哌嗪产品.

    海关参考信息

    专利信息


    专利号:US-7360133-B2
    优先权日:2004-05-18
    标题:Method for creating a JTAG tap controller in a slice for use during custom instance creation to avoid the need of a boundary scan synthesis tool
    发明人:GOYAL SAKET; NGO JAMES
    权利人:LSI LOGIC CORP
    摘要:A method and system is provided for creating a tap controller in a slice for use during custom instance creation to avoid the need of a boundary scan synthesis tool. Aspects of the present invention include during slice creation, using a software tool to create a test access port (TAP) from slice resources; during instance creation, allowing a customer to design a custom chip using the software tool to select which structures to use on the slice; and based on the customer selections, reconfiguring at the instance level connections between the tap controller and the selected structures.

    专利号:US-11667666-B2
    优先权日:2020-01-20
    标题 :Methods and compositions for treatment of cancer
    发明人:SINGHAL ANUJ
    权利人:CFD RES CORPORATION
    摘要:In an aspect, the disclosure pertains to inhibitors of ANGPTL4; synthesis methods for making disclosed compounds; pharmaceutical compositions comprising disclosed compounds; methods of treating disorders of uncontrolled cellular proliferation, e.g., a cancer; and methods of treating a disease associated with an ANGPTL4 dysfunction using disclosed compounds and pharmaceutical compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present disclosure.

    专利号:WO-2022256480-A1
    优先权日:2021-06-03
    标 题:Arylcoumarin synthesis with azeotropic removal of water
    发明人:YANG SUIZHOU; YU OLIVER
    权利人:CONAGEN INC
    摘要:The present disclosure provides a method of preparing certain 3,4-dihydro-4-aryl coumarin derivatives. Cinnamic acid, or a certain derivative thereof, may react with phenol, or a certain derivative thereof (e.g., resorcinol), with removal of water azeotropically in the presence of a catalyst and an organic solvent to form a certain 3,4-dihydro-4-aryl coumarin derivative. The present disclosure also provides certain novel 3,4-dihydro-4-aryl coumarin derivatives, and compositions, kits, and methods of use thereof.

    专利号:US-11254754-B2
    优先权日:2016-01-17
    标 题 :Biocompatible polysaccharide hydrogels and methods of usage
    发明人:SUN GUOMING
    权利人:SUN GUOMING
    摘要:The disclosure provides hydrogel compositions comprising polysaccharides with repeat units and methods of synthesis and usage.

    专利号:EP-0605446-A1
    优先权日:1991-09-03
    标 题:Procedure for synthesis of a white or light-coloured cross-linked halogen containing polymer

    专利号:EP-3137636-A1
    优先权日:2014-04-28
    标题:Dc arc furnace synthesis of refined ferromanganese alloys and metal
    杭州欣曜成生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.xycbiochem.com
    企业联系电话:18006812693;18057179864👤
    📞杭州欣曜成生物科技有限公司 ⚠️参考联系方式
    联系人:孔先生
    电话:18006812693;18057179864
    手机:18006812693;18057179864
    传真:0571-88199298
    邮箱:sales@xycbiochem.com
    通信地址: 杭州市临安区青山湖街道钱坞路168号4幢南
    邮编: 310012
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:杭州市临安区青山湖街道钱坞路168号4幢南
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Bagdade JD, Subbaiah PV. Effects of estropipate treatment on plasma lipids and lipoprotein lipid composition in postmenopausal women. J Clin Endocrinol Metab. 1991 Feb;72(2):283-6. Review. doi: 10.2174/1875397301004010001.
    6: Klaiber EL, Broverman DM, Vogel W, Peterson LG, Snyder MB. Relationships of serum estradiol levels, menopausal duration, and mood during hormonal replacement therapy. Psychoneuroendocrinology. 1997 Oct;22(7):549-58. Epub 2006 Aug 28. Epub 2005 Oct 12.

    合成参考文献


    参考文献:10.1038/srep41619
    摘要:Yeh JT-, Nam K, Yeh JT-, Perrimon N. eUnaG: a new ligand-inducible fluorescent reporter to detect drug transporter activity in live cells. Scientific Reports. 2017 Feb 08;7(1):41619. doi: 10.1038/srep41619.
    参考文献:10.1007/s001980050148
    摘要:Ravn P, Alexandersen P, Møllgaard A. Bone Densitometry: A New, Highly Responsive Region of Interest in the Distal Forearm to Monitor the Effect of Osteoporosis Treatment. Osteoporosis International. 1999 Apr 01;9(4):277–83. doi: 10.1007/s001980050148.
    参考文献:10.1016/j.pscychresns.2006.01.001
    摘要:Greenberg DL, Payne ME, MacFall JR, Provenzale JM, Steffens DC, Krishnan RR. Differences in brain volumes among males and female hormone-therapy users and nonusers. Psychiatry Research: Neuroimaging. 2006 Oct;147(2-3):127–34. doi: 10.1016/j.pscychresns.2006.01.001.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知